Xin Ying Lee

7PUBLICATIONS
20CO-AUTHORS
Traditional Chinese medicine and treatmentsHealth psychologyEpidemiological modellingMolecular medicineToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 16, 2026
Long-Term Improvements Following Initial Migraine Response in Eptinezumab-Treated Participants With Migraine for Whom 2-4 Prior Preventive Treatments Have Failed.

Jessica Ailani, Messoud Ashina, Susanne F Awad

|Feb 11, 2026
Sustained Efficacy of Eptinezumab in Participants with Migraine for Whom Prior Preventive Treatments Failed and Who Self-reported Psychiatric Comorbidities: Post Hoc Analysis of the Placebo-controlled DELIVER Trial.

Patricia Pozo-Rosich, Cristina Tassorelli, Line Pickering Boserup

|Dec 15, 2025
Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2-4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER Trial.

Cristina Tassorelli, Amaal J Starling, Susanne F Awad

|Sep 23, 2025
Number Needed to Treat and Cost Per Responder Analysis of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in Adults for Whom Prior Preventive Treatments have Failed.

Dimos D Mitsikostas, Susanne F Awad, Rikke Kongerslev

|Aug 18, 2023
Meta-regression to explain the placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention.

Stephane Alexandre Regnier, Xin Ying Lee

|May 31, 2023
Estimating treatment effects on health utility scores for patients living with migraine: a post hoc analysis of the DELIVER trial.

Linus Jönsson, Stephane A Regnier, Steven Kymes

Pageof 2

Frequent Collaborators

5 joint publications

Susanne F Awad

4 joint publications

Line Pickering Boserup

2 joint publications

Jessica Ailani

2 joint publications

Stephane Alexandre Regnier